Water Intake and Weight Control in Older Adults

December 1, 2023 updated by: Brenda Davy, Virginia Polytechnic Institute and State University
This study is a randomized controlled intervention trial in adults aged 50+ years with overweight or obesity, which will compare three groups with different diet prescriptions: 1) pre-meal water consumption (500 ml, before each main meal) with a hypocaloric diet; 2) 1500 ml water consumed throughout the day with a hypocaloric diet; 3) hypocaloric diet with no instructions regarding water consumption. Smart water bottles will objectively assess water intake timing and volume. Urine osmolality, urine volume, and serum osmolality will be used as objective indicators of compliance with the water intake prescription. We will investigate changes in perceived hunger and fullness and appetite-regulating hormones as potential mechanisms by which premeal water could improve appetite regulation. We will also investigate the impact of water consumption and hydration on executive function capabilities, which may influence intervention adherence. Although increasing water intake could be an effective weight management strategy, no evidence-based recommendations exist for the timing of water intake needed for this benefit.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

375

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Brenda Davy, PhD RDN
  • Phone Number: 540-231-6784
  • Email: bdavy@vt.edu

Study Contact Backup

  • Name: Elaina Marinik, PhD
  • Phone Number: 540-231-0923
  • Email: emarinik@vt.edu

Study Locations

    • Virginia
      • Blacksburg, Virginia, United States, 24061
        • Recruiting
        • Virginia Tech
        • Contact:
          • Brenda M Davy, PhD
          • Phone Number: 540-231-6784
          • Email: bdavy@vt.edu
        • Contact:
        • Principal Investigator:
          • Brenda M Davy, PhD, RD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • aged 50+ years
  • BMI 25-40
  • weight stable (+/- 2 kg) in past 6 months
  • willing to provide consent and comply with study protocol

Exclusion Criteria:

  • usual plain drinking water intake >1500 ml/d
  • uncontrolled hypertension (>159/99 mmHg)
  • medical condition requiring specialized diet prescription (eg, T2D, CHF wih fluid restriction)
  • medical condition that precludes participating in a physical activity program (eg, orthopedic injury)
  • current or history of GI disease (eg, Crohn's), GI surgery, or medications which impact GI function
  • allergies or aversions to foods included in the test meals

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pre-meal water + Hypocaloric diet
premeal water ( 500 ml) before each main meal, three times per day + hypocaloric diet
Individuals will be randomly assigned to one of three groups. All individuals will receive counseling in a structured hypocaloric meal plan (1200-1500 kcal) that is consistent with a healthy dietary pattern as described by the Dietary Guidelines for Americans. This group will receive specific instructions for daily water intake timing and volume.
Experimental: Daily water + Hypocaloric diet
total daily water prescription (1500 ml/d) + hypocaloric diet
Individuals will be randomly assigned to one of three groups. All individuals will receive counseling in a structured hypocaloric meal plan (1200-1500 kcal) that is consistent with a healthy dietary pattern as described by the Dietary Guidelines for Americans. This group will receive specific instructions for total daily water intake.
Active Comparator: Hypocaloric Diet alone
hypocaloric diet with not instructions regarding water intake
Individuals will be randomly assigned to one of three groups. All individuals will receive counseling in a structured hypocaloric meal plan (1200-1500 kcal) that is consistent with a healthy dietary pattern as described by the Dietary Guidelines for Americans. This group will receive instructions in the hypocaloric diet, without specific fluid intake recommendations.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body weight change
Time Frame: weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase
Body weight change in weight loss and weight loss maintenance phases
weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in appetite sensations
Time Frame: weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase
Changes in hunger and fullness, assessed using 100mm Visual Analog Scales (VAS), in weight loss and weight loss maintenance phases. These changes may mediate adherence to the hypocaloric diet and weight loss outcomes.
weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase
Change in hydration status
Time Frame: weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase
Changes in hydration status, assessed using urine and serum osmolality, urine specific gravity, and serum sodium, in weight loss and weight loss maintenance phases. These changes may mediate intervention adherence.
weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase
Change in executive function (EF)
Time Frame: weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase
Changes in EF (attention, inhibition) assessed using ePRIME computerized tasks, in weight loss and weight loss maintenance phases. These changes may mediate intervention adherence.
weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in appetite hormones
Time Frame: weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase
Changes in appetite hormones, specifically blood concentrations of ghrelin, PYY 3-36, leptin, and CCK in response to a standardized test meal with an energy content of 25% estimated energy requirements.
weeks 0 to 12 in the weight loss phase, month 0 to 12 post weight loss phase

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Brenda Davy, PhD RDN, Virginia Polytechnic Institute and State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 13, 2023

Primary Completion (Estimated)

June 30, 2027

Study Completion (Estimated)

March 31, 2028

Study Registration Dates

First Submitted

April 12, 2023

First Submitted That Met QC Criteria

April 24, 2023

First Posted (Actual)

May 6, 2023

Study Record Updates

Last Update Posted (Actual)

December 5, 2023

Last Update Submitted That Met QC Criteria

December 1, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 22-624

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Overweight and Obesity

3
Subscribe